Literature DB >> 292735

Side effects of long-term treatment with human leukocyte interferon.

S Ingimarsson, K Cantell, H Strander.   

Abstract

Twenty-nine patients, 27 of them with osteosarcoma and two with juvenile laryngeal papilloma, were followed for an aggregate period of 365 months, during which time they received long-term treatment with human leukocyte interferon. The interferon was given by intramuscular injection either daily or three times a week; the dose was 3 x 10(6) standard units. During the course of the treatment, 12 distinct symptoms were recognized as possible side effects of the drug; the three most frequent symptoms occurring after injection were fever, local pain, and shivering. All but three of the patients reported between one and five symptoms. Partial purification of the interferon reduced or eliminated some, but not all, of the symptoms. All of the patients were treated on an ambulatory basis, and none had to discontinue the interferon therapy because of the side effects.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 292735     DOI: 10.1093/infdis/140.4.560

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  Suppression of normal human erythropoiesis by gamma interferon in vitro. Role of monocytes and T lymphocytes.

Authors:  S W Mamus; S Beck-Schroeder; E D Zanjani
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

2.  Immunologic characterization of a rhesus macaque H1N1 challenge model for candidate influenza virus vaccine assessment.

Authors:  Jason A Skinner; Sandra M Zurawski; Chie Sugimoto; Heather Vinet-Oliphant; Parvathi Vinod; Yaming Xue; Kasi Russell-Lodrigue; Randy A Albrecht; Adolfo García-Sastre; Andres M Salazar; Chad J Roy; Marcelo J Kuroda; SangKon Oh; Gerard Zurawski
Journal:  Clin Vaccine Immunol       Date:  2014-10-08

3.  Toxicity of interferon.

Authors:  G M Scott; D S Secher; D Flowers; J Bate; K Cantell; D A Tyrrell
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-25

4.  A phase I study of human lymphoblastoid interferon administered by continuous intravenous infusion.

Authors:  A Z Rohatiner; F R Balkwill; D B Griffin; J S Malpas; T A Lister
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

5.  Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination.

Authors:  S L Sacks; G H Scullard; R B Pollard; P B Gregory; W S Robinson; T C Merigan
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

Review 6.  Drug-induced hair loss and hair growth. Incidence, management and avoidance.

Authors:  A Tosi; C Misciali; B M Piraccini; A M Peluso; F Bardazzi
Journal:  Drug Saf       Date:  1994-04       Impact factor: 5.606

7.  Mechanisms of fever induced by recombinant human interferon.

Authors:  C A Dinarello; H A Bernheim; G W Duff; H V Le; T L Nagabhushan; N C Hamilton; F Coceani
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

8.  Augmentation of endotoxin fever by recombinant human beta interferon in rabbits.

Authors:  H Kawasaki; M Moriyama; A Tanaka
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

9.  Viral pneumonia in children.

Authors:  Kelly J Henrickson
Journal:  Semin Pediatr Infect Dis       Date:  2006-06-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.